Insmed (INSM) News Today $100.10 -1.49 (-1.46%) As of 09:48 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock INSM Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Wells Fargo Lifts Price Target on Insmed Incorporated (INSM) to $119 From $107June 17 at 1:11 PM | msn.comAssenagon Asset Management S.A. Has $3.04 Million Holdings in Insmed Incorporated (NASDAQ:INSM)Assenagon Asset Management S.A. cut its holdings in Insmed Incorporated (NASDAQ:INSM - Free Report) by 92.4% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 39,778 shares of the biopharmaceutical company's stock after selling 485,415 shareJune 17 at 3:33 AM | marketbeat.comInsmed (NASDAQ:INSM) Reaches New 12-Month High - Should You Buy?Insmed (NASDAQ:INSM) Reaches New 52-Week High - Here's What HappenedJune 16 at 12:52 PM | marketbeat.comIs Insmed Stock Overvalued After The 45% Jump?June 16 at 5:32 AM | forbes.comSara Bonstein Sells 57,766 Shares of Insmed Incorporated (NASDAQ:INSM) StockJune 14, 2025 | insidertrades.comHandelsbanken Fonder AB Boosts Stock Position in Insmed Incorporated (NASDAQ:INSM)Handelsbanken Fonder AB raised its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 8.6% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 49,181 shares of the biopharmaceutical company's stock after bJune 14, 2025 | marketbeat.comResearch Analysts Issue Forecasts for Insmed FY2025 EarningsJune 14, 2025 | americanbankingnews.comInsmed Incorporated (INSM) Soars on Positive PAH Therapy Trial ResultsJune 13, 2025 | insidermonkey.comInsmed Incorporated (NASDAQ:INSM) Insider Orlov S. Nicole Schaeffer Sells 99,172 SharesJune 13, 2025 | insidertrades.comStocks To Watch: Insmed Sees RS Rating Jump To 93June 13, 2025 | msn.comInsmed (INSM) Soars After Raising $650 millionJune 13, 2025 | msn.comFY2025 Earnings Forecast for Insmed Issued By HC WainwrightInsmed Incorporated (NASDAQ:INSM - Free Report) - Research analysts at HC Wainwright increased their FY2025 EPS estimates for Insmed in a note issued to investors on Wednesday, June 11th. HC Wainwright analyst A. Fein now anticipates that the biopharmaceutical company will earn ($5.05) per shareJune 13, 2025 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) CFO Sara Bonstein Sells 57,766 SharesInsmed Incorporated (NASDAQ:INSM - Get Free Report) CFO Sara Bonstein sold 57,766 shares of the business's stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $89.12, for a total value of $5,148,105.92. Following the completion of the sale, the chief financial officer now directly owns 103,412 shares of the company's stock, valued at $9,216,077.44. The trade was a 35.84% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.June 13, 2025 | marketbeat.comFY2028 Earnings Estimate for Insmed Issued By HC WainwrightJune 13, 2025 | americanbankingnews.comPark Avenue Securities LLC Acquires 3,081 Shares of Insmed Incorporated (NASDAQ:INSM)Park Avenue Securities LLC lifted its holdings in Insmed Incorporated (NASDAQ:INSM - Free Report) by 38.7% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 11,036 shares of the biopharmaceutical company's stock after purchasing an additional 3,081June 13, 2025 | marketbeat.comInsmed (NASDAQ:INSM) Price Target Raised to $102.00June 13, 2025 | americanbankingnews.comInsmed (NASDAQ:INSM) Stock Price Expected to Rise, The Goldman Sachs Group Analyst SaysJune 13, 2025 | americanbankingnews.comInsmed (NASDAQ:INSM) Price Target Raised to $109.00 at Bank of AmericaJune 13, 2025 | americanbankingnews.comHC Wainwright Boosts Insmed (NASDAQ:INSM) Price Target to $120.00June 13, 2025 | americanbankingnews.comInsmed Incorporated (NASDAQ:INSM) Insider Sells $9,264,648.24 in StockInsmed Incorporated (NASDAQ:INSM - Get Free Report) insider Orlov S. Nicole Schaeffer sold 99,172 shares of the business's stock in a transaction dated Wednesday, June 11th. The stock was sold at an average price of $93.42, for a total value of $9,264,648.24. Following the transaction, the insider now directly owns 89,407 shares of the company's stock, valued at $8,352,401.94. The trade was a 52.59% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.June 12, 2025 | marketbeat.comInsmed Inc (INSM) Soars 30% on Impressive StudyJune 12, 2025 | insidermonkey.comEquities Analysts Issue Forecasts for Insmed FY2028 EarningsInsmed Incorporated (NASDAQ:INSM - Free Report) - Equities research analysts at HC Wainwright increased their FY2028 earnings estimates for Insmed in a research report issued to clients and investors on Wednesday, June 11th. HC Wainwright analyst A. Fein now anticipates that the biopharmaceuticalJune 12, 2025 | marketbeat.comInsmed prices capital raise of $750 via stock offeringJune 12, 2025 | msn.comMizuho Forecasts Strong Price Appreciation for Insmed (NASDAQ:INSM) StockJune 12, 2025 | americanbankingnews.comRoyal Bank of Canada Forecasts Strong Price Appreciation for Insmed (NASDAQ:INSM) StockJune 12, 2025 | americanbankingnews.comInsmed (NASDAQ:INSM) Stock Price Up 4.5% on Analyst UpgradeJune 12, 2025 | americanbankingnews.comInsmed Announces Pricing of $750 Million Public Offering of Common StockJune 11, 2025 | prnewswire.comAnalyst Kelly Shi from Jefferies Maintained a Buy Rating on Insmed Incorporated (INSM)June 11, 2025 | insidermonkey.com$100 Invested In Insmed 10 Years Ago Would Be Worth This Much TodayJune 11, 2025 | benzinga.comAnalyst Kelly Shi from Jefferies Maintained a Buy Rating on Insmed Incorporated (INSM)June 11, 2025 | msn.comInsmed Announces Proposed $650 Million Public Offering of Common StockJune 11, 2025 | prnewswire.comInsmed (NASDAQ:INSM) Given New $112.00 Price Target at The Goldman Sachs GroupThe Goldman Sachs Group boosted their target price on Insmed from $100.00 to $112.00 and gave the stock a "buy" rating in a report on Wednesday.June 11, 2025 | marketbeat.comInsmed's Pulmonary Hypertension Drug Data Exceeded Even Bullish Outlook, Analysts Boost Price ForecastJune 11, 2025 | benzinga.comInsmed (NASDAQ:INSM) Price Target Raised to $110.00Mizuho lifted their target price on shares of Insmed from $96.00 to $110.00 and gave the company an "outperform" rating in a report on Wednesday.June 11, 2025 | marketbeat.comInsmed (NASDAQ:INSM) Price Target Raised to $106.00 at Royal Bank of CanadaRoyal Bank of Canada boosted their price target on Insmed from $99.00 to $106.00 and gave the stock an "outperform" rating in a research report on Wednesday.June 11, 2025 | marketbeat.comMorgan Stanley Issues Positive Forecast for Insmed (NASDAQ:INSM) Stock PriceMorgan Stanley lifted their target price on Insmed from $90.00 to $102.00 and gave the company an "overweight" rating in a research report on Wednesday.June 11, 2025 | marketbeat.comInsmed (NASDAQ:INSM) Shares Up 4.5% After Analyst UpgradeInsmed (NASDAQ:INSM) Shares Up 4.5% Following Analyst UpgradeJune 11, 2025 | marketbeat.comBank of America Increases Insmed (NASDAQ:INSM) Price Target to $109.00Bank of America lifted their price target on shares of Insmed from $94.00 to $109.00 and gave the stock a "buy" rating in a report on Wednesday.June 11, 2025 | marketbeat.comWells Fargo & Company Raises Insmed (NASDAQ:INSM) Price Target to $119.00Wells Fargo & Company increased their target price on Insmed from $107.00 to $119.00 and gave the stock an "overweight" rating in a research report on Wednesday.June 11, 2025 | marketbeat.comHC Wainwright Issues Positive Forecast for Insmed (NASDAQ:INSM) Stock PriceHC Wainwright raised their price target on Insmed from $90.00 to $120.00 and gave the stock a "buy" rating in a report on Wednesday.June 11, 2025 | marketbeat.comHarbor Capital Advisors Inc. Buys 13,216 Shares of Insmed Incorporated (NASDAQ:INSM)Harbor Capital Advisors Inc. grew its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 22.2% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 72,816 shares of the biopharmaceutical compaJune 11, 2025 | marketbeat.comLeerink Partners Forecasts Strong Price Appreciation for Insmed (NASDAQ:INSM) StockJune 11, 2025 | americanbankingnews.comAnalysts Set Expectations for Insmed FY2026 EarningsJune 11, 2025 | americanbankingnews.comInsmed: Company Presses On With Further POC PAH Treatment DataJune 10, 2025 | seekingalpha.comInsmed (NASDAQ:INSM) Stock Price Expected to Rise, Leerink Partners Analyst SaysLeerink Partners upped their target price on shares of Insmed from $100.00 to $115.00 and gave the stock an "outperform" rating in a research report on Tuesday.June 10, 2025 | marketbeat.comInsmed stock soars on positive Phase 2b study resultsJune 10, 2025 | in.investing.cominsmed stock soars after positive results from phase 2b study of tpipJune 10, 2025 | au.investing.comTSMC revenue jump, Insmed stock skyrockets: Trending TickersJune 10, 2025 | finance.yahoo.comInsmed Shares Rise on Positive Results From Study of Treatment for High Blood Pressure in LungsJune 10, 2025 | marketwatch.comInsmed's drug for rare lung disease achieves 'home run' in mid-stage trialJune 10, 2025 | msn.com Get Insmed News Delivered to You Automatically Sign up to receive the latest news and ratings for INSM and its competitors with MarketBeat's FREE daily newsletter. Email Address INSM Media Mentions By Week INSM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INSM News Sentiment▼0.800.56▲Average Medical News Sentiment INSM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INSM Articles This Week▼5613▲INSM Articles Average Week Get Insmed News Delivered to You Automatically Sign up to receive the latest news and ratings for INSM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Zoetis News Today Regeneron Pharmaceuticals News Today Takeda Pharmaceutical News Today Alnylam Pharmaceuticals News Today Beigene News Today Teva Pharmaceutical Industries News Today Royalty Pharma News Today Summit Therapeutics News Today Genmab A/S News Today Intra-Cellular Therapies News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INSM) was last updated on 6/18/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredThe Shocking Link Between A.I. and Your MoneyThe AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored72 Hours Until Musk’s $34 Trillion AI Network BeginsIn just 72 hours, Elon Musk is expected to flip the switch on Tesla’s autonomous network in Austin, Texas. ...The Oxford Club | SponsoredSorry about the swear wordWhat a huge few months for Bitcoin. First, Bitcoin hit $100,000… Then, Donald Trump pledged to create an...Manward Press | SponsoredGold Just Jumped Again. Here’s How to Get PaidGold prices just spiked again. As I write this, gold is trading near $3,400 an ounce. But here's the thi...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Insmed, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Insmed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
